tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Ensysce Biosciences initiates Phase 3 study of PF614
PremiumThe FlyEnsysce Biosciences initiates Phase 3 study of PF614
4M ago
Ensysce Biosciences accelerates PF614-MPAR-102 study with full Part 2 enrollment
Premium
The Fly
Ensysce Biosciences accelerates PF614-MPAR-102 study with full Part 2 enrollment
4M ago
Ensysce Biosciences awarded $5.3M in continued NIDA support
Premium
The Fly
Ensysce Biosciences awarded $5.3M in continued NIDA support
5M ago
Ensysce Biosciences receives U.S. patent for OUD treatment
PremiumThe FlyEnsysce Biosciences receives U.S. patent for OUD treatment
6M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
7M ago
Ensysce Biosciences files to sell 980,000 shares of common stock for holders
Premium
The Fly
Ensysce Biosciences files to sell 980,000 shares of common stock for holders
7M ago
Ensysce Biosciences announces PAINWeek 2025 Symposium
PremiumThe FlyEnsysce Biosciences announces PAINWeek 2025 Symposium
8M ago
Ensysce Biosciences announces continued enrollment in PF614-MPAR trial
Premium
The Fly
Ensysce Biosciences announces continued enrollment in PF614-MPAR trial
9M ago
Ensysce Biosciences announces interim data for PF614-MPAR
Premium
The Fly
Ensysce Biosciences announces interim data for PF614-MPAR
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100